Acadia Pharmaceuticals buy Bank of America Co.
Start price
25.03.26
/
50%
€19.04
Target price
25.03.27
€24.99
Performance (%)
19.22%
Price
03.07.26
€22.70
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ currently has a performance of 19.22%. This prediction currently runs until 25.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 2.022% | 2.022% |
| iShares Core DAX® | 4.572% | 3.428% |
| iShares Nasdaq 100 | 1.832% | -1.036% |
| iShares Nikkei 225® | -0.289% | 3.380% |
| iShares S&P 500 | 2.229% | 0.472% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.15
30.06.26
30.06.26
€26.32
30.06.27
30.06.27
2.48%
03.07.26
03.07.26
